资讯
True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to ...
17 小时
Barchart on MSNJim Cramer Says You Should Buy This ‘Strong Buy’ Stock ‘Hand Over Fist’Eli Lilly (LLY) is a leading pharmaceutical company that discovers, develops, manufactures, and markets healthcare products.
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
22 小时
DISABLED ENTREPRENEUR UK on MSNThe Weight Loss Drug Craze: Miracle Solution or Medical Risk?As weight loss injections dominate the headlines, many wonder whether these so-called miracle drugs are truly safe, what ...
COMMENT: Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes ...
On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...
(Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果